A detailed, research-contextualized breakdown of every ingredient in the GlycoFree formula, including what the science says and what realistic dose expectations look like.
GlycoFree contains chromium at 400 mcg (fully disclosed) and a 200 mg proprietary blend of seven ingredients: berberine HCl, cinnamon extract 10:1, banaba extract, gymnema pentaphyllum, inulin, bitter melon extract, and L-leucine. Individual blend ingredient doses are not disclosed, which is an important transparency limitation discussed throughout this page.
Chromium is an essential trace mineral that plays a direct role in insulin signaling at the cellular level. The polynicotinate form is considered well-absorbed and is commonly used in supplementation research. At 400 mcg (1,143 percent of the Daily Value), this is the formula's only fully disclosed dose and falls within the range studied in clinical investigations of chromium's role in glucose metabolism.
Research on chromium supplementation has produced mixed results. Some studies show modest support for healthy fasting glucose levels, while others show no significant benefit beyond adequate dietary intake. Individual response may relate to baseline chromium status.
When ingredients are listed as a proprietary blend, individual amounts are not disclosed. With seven ingredients sharing 200 mg total, most cannot reach the doses used in clinical studies. This analysis is based on ingredient-level research and should be considered within that dose-limitation context.
Berberine is the most extensively researched ingredient in the blend. Studies have examined its effects on AMPK activation, glucose uptake, and hepatic glucose production. Clinical trials showing metabolic effects typically use 500 to 1,500 mg daily. The dose within the 200 mg total blend is likely a small fraction of this. Berberine also has documented interactions with certain medications via cytochrome P450 pathways — an important safety consideration covered on the side effects page.
Cinnamon has been studied for potential effects on insulin sensitivity and glucose transporters in skeletal muscle. Research results are inconsistent across trials. The 10:1 concentrate ratio provides more potency per milligram than raw powder. Studies typically use cinnamon equivalent to 1,000 to 6,000 mg of raw cinnamon daily, well above what is achievable in this blend's total budget.
Banaba leaf's primary active compound, corosolic acid, has been studied for its ability to support glucose uptake via GLUT4 transporter proteins in muscle cells. Notably, banaba may show activity at relatively lower doses compared to other botanicals on this list, making it potentially more viable within a constrained proprietary blend. The 1% corosolic acid standardization indicates meaningful quality control.
Gymnema contains gymnemic acids studied for their dual action on taste perception (reducing sweetness perception) and potential effects on intestinal glucose absorption and insulin function. Research doses typically range from 200 to 400 mg of standardized extract daily. The amount present within this blend is likely below that range.
Inulin is a soluble prebiotic fiber that feeds beneficial gut bacteria. It is included for its gut microbiome support potential, as emerging research connects microbiome health to metabolic function and insulin sensitivity. Research on inulin's metabolic effects uses 10 to 20 grams daily, far exceeding what a 200 mg blend can provide. At available doses, inulin contributes primarily as a mild prebiotic and is the most likely contributor to the digestive adjustment some users experience in the first week.
Bitter melon contains charantin, vicine, and polypeptide-p, compounds studied across traditional medicine systems and modern research for potential insulin-supporting properties. Clinical studies have produced variable results. Research doses involve 1,000 to 2,000 mg of extract equivalent daily, well beyond the capacity of this blend.
L-leucine is an essential branched-chain amino acid primarily associated with muscle protein synthesis. Some research explores its role in insulin signaling and muscle glucose uptake pathways. Its inclusion in a blood sugar formula is less conventional than the other ingredients here. At low doses, significant standalone metabolic effects are unlikely.
| Ingredient | Disclosed Dose | Clinical Research Range | Assessment |
|---|---|---|---|
| Chromium | 400 mcg | 200–1,000 mcg/day | Within Range |
| Berberine HCl | Not disclosed | 500–1,500 mg/day | Likely Sub-Clinical |
| Cinnamon Extract | Not disclosed | 1,000–6,000 mg equiv. | Likely Sub-Clinical |
| Banaba Extract | Not disclosed | Lower dose possible | Possibly Partial |
| Gymnema Extract | Not disclosed | 200–400 mg/day | Likely Sub-Clinical |
| Inulin | Not disclosed | 10,000–20,000 mg/day | Likely Sub-Clinical |
| Bitter Melon | Not disclosed | 1,000–2,000 mg/day | Likely Sub-Clinical |
| L-Leucine | Not disclosed | Variable by application | Uncertain |
For the full review of GlycoFree including pricing and guarantee details, see the main GlycoFree review.
GlycoFree contains chromium (400 mcg, disclosed) and a 200 mg proprietary blend of berberine HCl, cinnamon extract 10:1, banaba extract (1% corosolic acid), gymnema pentaphyllum extract, inulin, bitter melon extract 4:1, and L-leucine.
Clinical research on berberine for glucose metabolism uses 500 to 1,500 mg daily. With seven ingredients sharing a total of 200 mg in the proprietary blend, the berberine dose in GlycoFree is likely well below clinical research amounts. Sub-clinical combinations may still provide some benefit, but the dose limitation is a meaningful consideration.
Chromium is an essential trace mineral involved in insulin signaling. It may support insulin receptor sensitivity, helping cells respond more efficiently to insulin. At 400 mcg, GlycoFree's chromium dose falls within the range studied in clinical research.
No. The GlycoFree ingredient list does not include stimulants such as caffeine or synephrine. The formula focuses on botanical extracts, a mineral, a prebiotic fiber, and an amino acid.
L-leucine is an essential branched-chain amino acid more commonly associated with muscle protein synthesis. Some research explores its role in insulin signaling and muscle glucose uptake, though its inclusion in a blood sugar formula is less conventional. At the low doses likely present in the proprietary blend, significant metabolic effects from leucine alone would not be expected.